Addiction treatment in Louisiana

There is no gentle way to start this. Louisiana has 366 licensed addiction-treatment facilities, a specific place in the Gulf South, and a specific version of the national crisis. The specific version matters, because a conversation that works for a family in another state will not land the same way here.

The Medicaid question

Louisiana expanded Medicaid in 2016 under the Affordable Care Act. What that means in practice: a low-income adult in Louisiana with substance use disorder has realistic access to Medicaid coverage for addiction treatment once enrolled. This is the single largest variable in whether treatment is financially reachable — larger than any specific facility's sliding-scale policy or any commercial plan's network.

The overdose-mortality context

The raw number — 55.9 overdose deaths per 100,000 in Louisiana — matters less than what it tells you about where treatment could intervene. Most deaths involve opioids, and most opioid deaths in the state now involve illicitly manufactured fentanyl. That is the single biggest shift in the clinical landscape since 2015, and it is the thing treatment programs in Louisiana have had to adapt to.

How access actually works in Louisiana

What to do first if you are in Louisiana and trying to find help: call your insurance plan's behavioral-health line (not the general member-services line), and ask specifically which in-network facilities offer medication-assisted treatment. The word "in-network" matters more than the word "nearby"; under the 2024 parity rule, if your plan claims in-network access and does not actually deliver it, you have a real appeal path.

What to do next

The steps that help most families in Louisiana are not the ones that feel most productive. Calling ten facilities and collecting brochures often produces worse results than a single honest conversation with a primary-care doctor, a licensed substance-use counselor, or a trusted clinician who can refer into Louisiana's specific treatment network. Start with someone whose incentives are clinical, not commercial.